Fostemsavir to overcome drug-drug interactions in heavily treatment-experienced people with HIV and cancer

J Antimicrob Chemother. 2024 Jul 1;79(7):1708-1709. doi: 10.1093/jac/dkae121.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Drug Interactions*
  • Female
  • HIV Infections* / drug therapy
  • Humans
  • Male
  • Middle Aged
  • Neoplasms* / drug therapy
  • Organophosphates* / pharmacology
  • Organophosphates* / therapeutic use
  • Piperazines

Substances

  • fostemsavir
  • Organophosphates
  • Anti-HIV Agents
  • Piperazines